Hafrun Fridriksdottir, Executive VP, Global R&D at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 101,720 shares at $9.95 ($1.0M) on 2021-08-10, disclosed to the SEC on 2021-08-12.
Open-market sale of $1.0M TEVA by Executive VP, Global R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.95 | 50,860 | $506K | 50.0% |
| 2 | $9.95 | 50,860 | $506K | 50.0% |
| Total | $9.95 avg | 101,720 | $1.0M | 100% |
| Filing → |
| TEVA | SELL | 2022-03-02 | $124K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $111K | — | Filing → |
| TEVA | SELL | 2021-05-13 | $390K | — | Filing → |